The aims of this study were (i) to assess the prevalence and spectrum of codon 12 Ki-ras mutations in patients diagnosed with exocrine pancreatic cancer (EPC) in 2 general hospitals between 1980 and 1990, (ii) to analyze the association of this genetic alteration with clinical and pathological chara
FREQUENCY AND CLINICO-PATHOLOGICAL ASSOCIATIONS OF RAS MUTATIONS IN COLORECTAL CANCER IN THE VICTORIAN POPULATION
β Scribed by Robert J. S. Thomas; Yong-Shu Liu; Fiona St Clair; Pamela M. Norris; Renata Valentine; Wayne A. Phillips
- Book ID
- 108994238
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 809 KB
- Volume
- 67
- Category
- Article
- ISSN
- 1445-1433
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Epidemiological observations suggest that cancer arises from chronically inflamed tissues. Inflammatory bowel disease (IBD) is a typical example since patients with longstanding IBD are at increased risk for development of colorectal cancer (CRC). Therefore, genetic factors predisposing
Colorectal cancer is one of the most common malignancies in the western world. About 60,000 Americans die of colorectal cancer each year. The annual incidence rate in Israel is 40 per 100,000 persons, namely a total of 2,000 new cases each year. An important step in the progression of colorectal can
## Abstract Recently, __RASSF2A__ was identified as a potential tumor suppressor epigenetically inactivated in human cancers. Here, we evaluated the methylation status of __RASSF2A__ in colorectal cancer (CRC) and analyzed its correlation with Kβ__ras__/__BRAF__ mutations, microsatellite instabilit